Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine versus haloperidol for delirium in advanced cancer
NL-OMON39561Phase 3Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in delirium comparing Olanzapine with Haloperidol (2 arms). Primary endpoints: Delirium response/recovery and Validation of Delirium Observation Screening Scale. Started Mar 2010; status: active, not recruiting.
02
Drugs
olanzapinehaloperidol
03
Conditions
delirium
Beyond the preview
Go deeper on NL-OMON39561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39561.